Prescription Drug Marketing actual Collection- trends in prescription drug marketing - the promotion of academic specialization.docVIP

 PAGE \* MERGEFORMAT 29 ‘Prescription Drug Marketing actual Collection’: trends in prescription drug marketing - the promotion of academic specialization In 2008 the global financial crisis, the state implemented a series of macro-control policies, the pharmaceutical industry showing a decline of non-prescription drugs, functional product growth. Introduction of the medical reform, the state’s emphasis on rural markets, as well as 4 trillion yuan to boost domestic demand and investment, are positive throughout the pharmaceutical industry, a large number of prescription drugs into the health insurance directory, a number of therapeutic drugs directly from the basic primary health care free of charge, undoubtedly mean that more and more people will go to clinics and hospitals in order to prescribe the form of access to treatment. Along with the GMP, GSP, GCP, GLP, GAP, etc. successively promulgated various policies, prescription drug sales to the positive trend is indisputable. According to IMS in 2008 published a study report shows that in 2008 global sales of prescription drugs nearly 745 billion U.S. dollars, are projected in 2007 an increase of 5% to 6%. In China, Brazil, Turkey and Mexico, a fast-growing countries, sales of prescription drugs was rapid growth is expected in 2009 will occupy 25% of the global prescription drug market, while two years ago, these countries and regions combined market share is not over 10%. In addition, the Boston consulting firm, in a statistical report that as China’s major consumer of prescription drugs is increasing the proportion of elderly people, and the average life expectancy in China has risen to 70 years; China’s per capita GDP increasing purchasing power will become increasingly serious . Report: 2010 China’s prescription drug sales will reach 24 billion U.S. dollars, becoming the world’s fifth-largest prescription drug market (see Table 0-1). Face of China’s prescription drug market so attractive prospects, man